PCM
PETS icon

Prelude Capital Management’s PetMed Express PETS Stock Holding History

Prelude Capital Management’s Portfolio PETS Stock Details PETS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-200
Closed -$4K – 2168
2019
Q3 		$4K Hold
200
– – ﹤0.01% 1586
2019
Q2 		$3K Sell
200
-100
-33% -$1.97K ﹤0.01% 1552
2019
Q1 		$7K Buy
+300
New +$6.76K ﹤0.01% 1595

Other funds holding PETS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.2B AUM 41.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

Prelude Capital Management's PETS Position: Q2 2021 in Review

Prelude Capital Management sold out of PetMed Express (PETS) in Q2 2021, closing a stake of 14,802 shares — an estimated $470K sold.

Prelude Capital Management first reported a position in PETS in Q3 2013 and held it in 13 quarters. The position peaked at $522K in Q4 2020. 199 funds tracked by Wall St. Rank hold PETS as of Q2 2021.

  • Prelude Capital Management reported no remaining PetMed Express position as of Q2 2021 after selling out during the quarter.
  • Prelude Capital Management sold 14,802 PetMed Express shares in Q2 2021, an estimated $470K.
  • Prelude Capital Management first reported a position in PetMed Express in Q3 2013 and held it in 13 quarters.
  • Prelude Capital Management's PetMed Express position peaked at $522K in Q4 2020.
  • 199 funds tracked by Wall St. Rank held PetMed Express as of Q2 2021.

Based on Prelude Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.